The use of an anti‐CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low‐dose tacrolimus and early withdrawal of steroids in renal transplant recipients

Abstract
Background: Reducing calcineurin‐inhibitor‐induced nephrotoxicity and simultaneously avoiding long‐term steroid related side‐effects is a desirable goal in renal transplantation. We examin...